The POC Molecular Diagnostics Market was valued at USD 3.37 billion in 2021 and is projected to reach USD 6.27 billion by 2030. The market is anticipated to expand at a healthy CAGR of 14% over the forecast period. The rising prevalence of serious diseases and cancer, increased focus on decentralised diagnostics, increased R&D investment, increased awareness of the early diagnosis of infectious diseases, and increased usage of point-of-care diagnostic tests are all driving market expansion.
INDUSTRY OVERVIEW
Point-of-Care (POC) molecular diagnostics are tests conducted in close proximity to the patient, such as in clinics, hospitals, and ambulances. Oncology, coagulation, antigen typing, human leukocyte, infectious illnesses, and genetic disease screening are all currently performed using molecular diagnostic techniques. Speedier development and commercialization of innovative and more advanced technologies, as well as the faster movement of such advanced tests from labs to point of care (POC) settings, are driving the worldwide market growth. The rising incidence of various malignancies and infectious disease types is expected to be a prominent driver driving market expansion in the approaching years. Growing knowledge and acceptance of improved treatment and diagnostic options such as personalised medicine, biomarker discovery, and advances in proteomics and molecular methods are other major drivers driving growth.
Reforms in reimbursement policies are also helping to boost market expansion to some extent. Another key growth driver for the market is the growing usage of molecular diagnostics for home healthcare. Another factor driving growth in the molecular diagnostics market is the increasing use of healthcare information technology to provide precise diagnoses. New diagnostic tests, mainly in the infectious disease application field, are expected to keep the molecular diagnostics momentum continuing in the coming years.
COVD-19 IMPACT ON THE POC MOLECULAR DIAGNOSTICS MARKET
Most companies' overall sales were affected by the COVID-19 outbreak. The introduction of COVID-19 testing molecular diagnostic technology, however, had a favourable impact on the point-of-care molecular diagnostics industry. Because of the COVID-19 pandemic, people postponed getting their health evaluated, resulting in fewer tests and reagent sales. However, as nations relax travel restrictions, the number of people who get tested is growing. As a result, the global response to the COVID-19 epidemic has been spearheaded by molecular diagnostics. Molecular diagnostics, on the other hand, have significant limitations. Modern molecular diagnostics are designed to be used as a core diagnostic solution for doing large numbers of tests in a reasonable length of time, rather than for COVID-19 point-of-care diagnosis. As a result, pinpointing the disease's origin is crucial to preventing its spread. As a result, the market grew throughout the epidemic and will continue to rise in the following years.
MARKET DRIVERS:
The increasing prevalence of chronic and infectious diseases throughout the world is driving up the demand for point-of-care diagnostics
Across the globe, chronic illnesses such as cardiovascular disease, diabetes, and different infectious diseases are on the rise. One of the primary reasons driving demand for point-of-care diagnostics throughout the predicted period is the rising prevalence rate of such diseases.
According to the United Nations, about 38 million people were living with HIV/AIDS in 2019. There were 1.8 million youngsters and 36.2 million adults among them. Furthermore, the human respiratory syncytial virus (RSV) is one of the most prevalent viruses to infect the respiratory tract. According to the Centers for Disease Control and Prevention (CDC), 4-5 million children worldwide contract respiratory syncytial virus (RSV) lower respiratory tract infection each year. Similarly, the IDF Diabetes Atlas estimates that 206.0 million persons worldwide will have diabetes in 2021. Additionally, by 2030, the worldwide population of diabetic individuals is anticipated to reach 643 million, and by 2045, it will reach 783 million. A large increase in the incidence of diabetes and the other chronic diseases stated above has created a need for quick point-of-care diagnostics to efficiently manage such conditions, and the market is expected to develop at a favourable rate globally.
The propagation of a decentralized healthcare system to aid market expansion
Rapid diagnostic testing is expected to grow in popularity in decentralised settings since it allows for immediate access to medical equipment and removes the need for transportation. These developments will have a beneficial impact on worldwide market growth. Since immediate diagnosis reports are essential for accurate and faster therapeutic interventions, point-of-care testing has become critical for patient-centric healthcare. Patients now have accessible access to these diagnostics thanks to a transition from centralised point-of-care testing to decentralised testing for chronic and infectious diseases. As the demand for quick turnaround testing has grown, various companies have developed infectious disease diagnostics for dispersed settings. As a result, the need for decentralised healthcare settings has risen in response to the growing desire for quick and effective diagnostics that may be conducted at home or a physician's office for patient convenience.
MARKET RESTRAINTS:
Adoption is being hampered by the inaccuracy of point-of-care diagnostics
In the field of point-of-care testing, pre-analytical mistakes are common. As a result, such situations may limit new product releases, limiting industry growth. For example, Siemens Healthcare issued a Class 2 Device Recall in August 2020 for their BGEM Evaluate Card In-vitro Diagnostic Device, which is used to objectively test capillary whole blood, venous, or unanticoagulated arterial in the laboratory or at the point of care. This was due to the card lot 01-20095-10's irregular glucose values. This might lead to a delay in detecting hyperglycemia or needless hypoglycemic therapy. As a result, throughout the projection period, the lack of precision in POC testing is likely to limit market growth globally.
An unfavourable reimbursement scenario may act as a hindrance to market growth
Unsatisfactory reimbursements policies are a key stumbling block to the point-of-care molecular diagnostics market's expansion. Most diagnostic firms have significant difficulty in commercialising their tests: convincing Medicare and private health insurers to pay for them. In 2018, Medicare in the United States changed its reimbursement policy for various IVD tests, including point-of-care molecular diagnostics. Some of these tests don't have their codes in the Healthcare Common Procedure Coding System (HCPCS), thus they're invoiced with unlisted codes. Medicare Administrative Contractors (MACs) set a payment amount for their local jurisdictions in such circumstances. The Medicare reimbursement rate for COVID-19 tests based on high throughput technology has been decreased to USD 75 unless laboratories can process findings in less than two days, according to the Centers for Medicare & Medicaid Services (CMS). Thus, the unfavourable reimbursement policies are having a negative impact on the market growth.
This research report on the POC Molecular Diagnostics Market has been segmented and sub-segmented based on By Product, By Test location, By Technology, By Application and By Region.
Based on products, the POC Molecular Diagnostics Market is segmented into Instruments, Reagents and Others. In 2021, the reagents category had the most revenue share in the market. Because of its widespread use in research and clinical contexts, it is projected to retain its prominence in the future years. Standard reagents aid in the production of timely and accurate findings. The market is projected to grow due to standardised outcomes, increased efficiency, and cost-effectiveness.
In addition, the increasing usage of tools to detect coronavirus, which was previously developed for other infectious disorders, is supposed to propel market expansion. For example, Roche Diagnostics expanded its Covid RT-PCR assays offering to include the new Cobas 5800 system in February 2022 in countries that received the CE mark approval.
Based on test location, the POC Molecular Diagnostics Market is segmented into Point-of-Care
Self-test or Over the Counter and Central Laboratories. Due to high treatment volumes for Covid testing in central labs, central laboratories held the greatest share of the market in 2021. Another key driver estimated to boost the market is a growth in the number of government efforts to provide various services, such as payment for diagnostic testing.
The development of molecular diagnostic platforms that may be employed in PoC scenarios is gaining popularity. As a result, several businesses are developing assays and molecular diagnostic platforms for point-of-care (POC) or near-patient testing. In addition, market growth is expected to be aided by the increasing development of novel assays that provide speedy PoC findings.
Based on technology, the POC Molecular Diagnostics Market is segmented into PCR-based, Genetic Sequencing-based, Hybridization-based and Microarray-based. The PCR category commanded more than 58 per cent of the market share in 2020, thanks to increasing precision and accuracy as well as the expansion of its application. Furthermore, RT-PCR and DNA/RNA purification are gaining popularity due to advantages such as minimal reagent use, real-time process monitoring, workflow automation, and improved accuracy and repeatability. As a result, rising rates of genetic abnormalities and infectious illnesses, as well as increased public-private investments, grants, and financing for PCR-based research will further aid in market expansion.
Based on applications, the POC Molecular Diagnostics Market is segmented into Infectious Diseases, Oncology, Hematology, Prenatal Testing and Endocrinology among others. The infectious illness segment generated a revenue of USD 2 billion in 2021. The dominance of this sector is due to the growing use of molecular diagnostics, particularly PCR tests, for the diagnosis of COVID-19. The sector will expand as laboratory capacity for infectious disease diagnostics and early identification of developing pandemic strains grows. Over the forecast period, the rising prevalence of infectious disease among the elderly, newborn newborns, and persons with certain chronic conditions will drive the expansion. Additionally, the rising availability of rapid testing will affect future product demand, resulting in more applications in faster disease diagnosis. Traditional testing flaws include long turnaround times, poor in vitro kinetic development, difficulties cultivating organisms in manually produced culture medium, and lack of sensitivity that has been mitigated by technology advances like PCR and ISH and thus is propelling the segmental growth.
By region, the POC Molecular Diagnostics Market is grouped into North America, Europe, Asia Pacific, Latin America, The Middle East and Africa. Throughout the forecast period, the Asia Pacific area is expected to have the quickest CAGR. The increasing prevalence of chronic diseases due to ageing demography, the emergence of key market players operating in the market, a lack of advanced central laboratory testing services, and the potential cost-effectiveness of POC molecular diagnosis are driving the Asia Pacific POC molecular diagnostics market. In 2020, the market for point-of-care molecular diagnostics in North America was worth more than USD 1.4 billion. The expanding use of POC tests for safe and early diagnosis, as well as the rising prevalence of infectious illnesses, will drive up demand for such quick testing. Moreover, throughout the projected period, governments and key market players would invest heavily in research and development to develop POC molecular diagnostic tests, which will boost market revenue. As the number of cases of COVID-19 in the region rises, so will the use of point-of-care molecular diagnostic kits to effectively treat the condition. Furthermore, the increasing usage of PCR-based diagnostic methods and the commercialization of real-time PCR products will have an impact on regional demand. In 2021, Europe contributed 27.4 per cent of total sales. This may be ascribed to the increased epidemiology of infectious and chronic illnesses, which has boosted market growth by stimulating R&D activity. The high level of life, as well as consumer awareness of early diagnosis and a well-established healthcare system, are major growth factors.
POC MOLECULAR DIAGNOSTICS MARKET - BY COMPANIES
The market for molecular diagnostics at the point of care is concentrated. The bulk of point-of-care molecular testing methods is developed by globally leading companies. Industry leaders have built their position in the market by investing more in research and having a superior distribution system. Furthermore, due to increased awareness, Asia-Pacific is seeing the rise of several minor companies, which has aided the market's growth. Some of the major players operating in the POC Molecular Diagnostics Market include:
NOTABLE HAPPENING IN POC MOLECULAR DIAGNOSTICS MARKET
PRODUCT LAUNCH- Seegene announced the introduction of their forthcoming Allplex SARS-CoV-2 Fast PCR Assay in January 2022. The test has a 60-minute turnaround time, making it ideal for bulk testing.
PRODUCT LAUNCH- Biodesix launched the GeneStrat NGSTM Test, a blood-based tumour profiling test, in January 2022 to help clinicians treat severe lung cancer based on mutations.
ACQUISITION- Roche bought GenMark Diagnostics for USD 1.8 billion in May 2021. Roche will be able to increase its molecular diagnostics range as a result of this takeover.
COLLABORATION- In October 2020, bioMérieux SA joined with Africa Medical Supplies Platform (AMSP) to provide African Union Member States with high-quality COVID-19 testing tools from the bioMérieux Pandemic Response Array.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
